nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—SLC22A5—Dactinomycin—uterine cancer	0.291	0.495	CbGbCtD
Cephalexin—CYP2D6—Progesterone—uterine cancer	0.0877	0.149	CbGbCtD
Cephalexin—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0842	0.143	CbGbCtD
Cephalexin—CYP3A4—Progesterone—uterine cancer	0.0558	0.095	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—uterine cancer	0.0268	0.0456	CbGbCtD
Cephalexin—CYP3A4—Etoposide—uterine cancer	0.025	0.0425	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—uterine cancer	0.017	0.029	CbGbCtD
Cephalexin—SLC47A1—myometrium—uterine cancer	0.00372	0.0534	CbGeAlD
Cephalexin—SLC15A1—epithelium—uterine cancer	0.00311	0.0447	CbGeAlD
Cephalexin—SLC47A1—uterine cervix—uterine cancer	0.00289	0.0415	CbGeAlD
Cephalexin—SLC15A1—renal system—uterine cancer	0.00288	0.0414	CbGeAlD
Cephalexin—SLC15A1—endometrium—uterine cancer	0.00279	0.0401	CbGeAlD
Cephalexin—SLC47A1—decidua—uterine cancer	0.00275	0.0396	CbGeAlD
Cephalexin—SLC47A1—renal system—uterine cancer	0.0027	0.0389	CbGeAlD
Cephalexin—SLC15A1—mammalian vulva—uterine cancer	0.0027	0.0388	CbGeAlD
Cephalexin—SLC47A1—endometrium—uterine cancer	0.00261	0.0376	CbGeAlD
Cephalexin—SLC47A1—mammalian vulva—uterine cancer	0.00253	0.0363	CbGeAlD
Cephalexin—SLC47A1—uterus—uterine cancer	0.00241	0.0346	CbGeAlD
Cephalexin—SLC47A1—female reproductive system—uterine cancer	0.00217	0.0311	CbGeAlD
Cephalexin—SLC22A5—myometrium—uterine cancer	0.00215	0.0309	CbGeAlD
Cephalexin—SLC15A1—vagina—uterine cancer	0.00209	0.03	CbGeAlD
Cephalexin—SLC22A8—renal system—uterine cancer	0.00207	0.0298	CbGeAlD
Cephalexin—SLC47A1—female gonad—uterine cancer	0.00197	0.0283	CbGeAlD
Cephalexin—SLC47A1—vagina—uterine cancer	0.00196	0.0281	CbGeAlD
Cephalexin—SLC15A2—uterine cervix—uterine cancer	0.00193	0.0277	CbGeAlD
Cephalexin—SLC15A2—renal system—uterine cancer	0.0018	0.0259	CbGeAlD
Cephalexin—SLC15A2—endometrium—uterine cancer	0.00174	0.025	CbGeAlD
Cephalexin—SLC22A5—uterine cervix—uterine cancer	0.00168	0.0241	CbGeAlD
Cephalexin—SLC22A5—renal system—uterine cancer	0.00157	0.0225	CbGeAlD
Cephalexin—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00451	CcSEcCtD
Cephalexin—Mental disorder—Progesterone—uterine cancer	0.00153	0.00445	CcSEcCtD
Cephalexin—SLC22A5—endometrium—uterine cancer	0.00152	0.0218	CbGeAlD
Cephalexin—Vaginal discharge—Doxorubicin—uterine cancer	0.00151	0.00441	CcSEcCtD
Cephalexin—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00435	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Etoposide—uterine cancer	0.00148	0.00432	CcSEcCtD
Cephalexin—Pancytopenia—Dactinomycin—uterine cancer	0.00146	0.00426	CcSEcCtD
Cephalexin—SLC15A2—female reproductive system—uterine cancer	0.00144	0.0207	CbGeAlD
Cephalexin—Neutropenia—Dactinomycin—uterine cancer	0.00144	0.00419	CcSEcCtD
Cephalexin—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00415	CcSEcCtD
Cephalexin—Angioedema—Progesterone—uterine cancer	0.00139	0.00404	CcSEcCtD
Cephalexin—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00403	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00136	0.00396	CcSEcCtD
Cephalexin—SLC15A2—female gonad—uterine cancer	0.00131	0.0189	CbGeAlD
Cephalexin—Convulsion—Progesterone—uterine cancer	0.00131	0.00383	CcSEcCtD
Cephalexin—SLC15A2—vagina—uterine cancer	0.00131	0.0188	CbGeAlD
Cephalexin—Arthralgia—Progesterone—uterine cancer	0.00129	0.00376	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00128	0.00374	CcSEcCtD
Cephalexin—Agranulocytosis—Dactinomycin—uterine cancer	0.00128	0.00373	CcSEcCtD
Cephalexin—SLC47A1—lymph node—uterine cancer	0.00127	0.0182	CbGeAlD
Cephalexin—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00368	CcSEcCtD
Cephalexin—SLC22A5—female reproductive system—uterine cancer	0.00126	0.018	CbGeAlD
Cephalexin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00126	0.00366	CcSEcCtD
Cephalexin—Confusional state—Progesterone—uterine cancer	0.00125	0.00364	CcSEcCtD
Cephalexin—Anaphylactic shock—Progesterone—uterine cancer	0.00124	0.00361	CcSEcCtD
Cephalexin—Hepatitis—Dactinomycin—uterine cancer	0.00123	0.00359	CcSEcCtD
Cephalexin—Nervous system disorder—Progesterone—uterine cancer	0.00121	0.00354	CcSEcCtD
Cephalexin—Skin disorder—Progesterone—uterine cancer	0.0012	0.0035	CcSEcCtD
Cephalexin—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00347	CcSEcCtD
Cephalexin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00341	CcSEcCtD
Cephalexin—Erythema multiforme—Dactinomycin—uterine cancer	0.00116	0.00339	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00339	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00116	0.00338	CcSEcCtD
Cephalexin—SLC22A5—female gonad—uterine cancer	0.00114	0.0164	CbGeAlD
Cephalexin—SLC22A5—vagina—uterine cancer	0.00114	0.0163	CbGeAlD
Cephalexin—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00114	0.00331	CcSEcCtD
Cephalexin—Jaundice cholestatic—Epirubicin—uterine cancer	0.00113	0.0033	CcSEcCtD
Cephalexin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00113	0.00329	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00113	0.00329	CcSEcCtD
Cephalexin—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00327	CcSEcCtD
Cephalexin—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.0032	CcSEcCtD
Cephalexin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.0032	CcSEcCtD
Cephalexin—Arthropathy—Epirubicin—uterine cancer	0.00109	0.00319	CcSEcCtD
Cephalexin—Dyspepsia—Progesterone—uterine cancer	0.00109	0.00317	CcSEcCtD
Cephalexin—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00317	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Progesterone—uterine cancer	0.00107	0.00311	CcSEcCtD
Cephalexin—Fatigue—Progesterone—uterine cancer	0.00107	0.00311	CcSEcCtD
Cephalexin—Pancytopenia—Etoposide—uterine cancer	0.00106	0.00308	CcSEcCtD
Cephalexin—Blood bilirubin increased—Epirubicin—uterine cancer	0.00105	0.00306	CcSEcCtD
Cephalexin—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00105	0.00305	CcSEcCtD
Cephalexin—Creatinine increased—Epirubicin—uterine cancer	0.00104	0.00304	CcSEcCtD
Cephalexin—Neutropenia—Etoposide—uterine cancer	0.00104	0.00303	CcSEcCtD
Cephalexin—CYP3A4—renal system—uterine cancer	0.00103	0.0148	CbGeAlD
Cephalexin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00298	CcSEcCtD
Cephalexin—Feeling abnormal—Progesterone—uterine cancer	0.00102	0.00297	CcSEcCtD
Cephalexin—ALB—lymph node—uterine cancer	0.00101	0.0145	CbGeAlD
Cephalexin—CYP2D6—renal system—uterine cancer	0.00101	0.0145	CbGeAlD
Cephalexin—Arthropathy—Doxorubicin—uterine cancer	0.00101	0.00295	CcSEcCtD
Cephalexin—Gastrointestinal pain—Progesterone—uterine cancer	0.00101	0.00295	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000995	0.0029	CcSEcCtD
Cephalexin—Vaginal inflammation—Epirubicin—uterine cancer	0.000995	0.0029	CcSEcCtD
Cephalexin—Infestation NOS—Etoposide—uterine cancer	0.000993	0.00289	CcSEcCtD
Cephalexin—Infestation—Etoposide—uterine cancer	0.000993	0.00289	CcSEcCtD
Cephalexin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00288	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.000984	0.00287	CcSEcCtD
Cephalexin—Urticaria—Progesterone—uterine cancer	0.000983	0.00286	CcSEcCtD
Cephalexin—Abdominal pain—Progesterone—uterine cancer	0.000978	0.00285	CcSEcCtD
Cephalexin—Body temperature increased—Progesterone—uterine cancer	0.000978	0.00285	CcSEcCtD
Cephalexin—Blood bilirubin increased—Doxorubicin—uterine cancer	0.000973	0.00284	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000968	0.00282	CcSEcCtD
Cephalexin—Creatinine increased—Doxorubicin—uterine cancer	0.000967	0.00282	CcSEcCtD
Cephalexin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000967	0.00282	CcSEcCtD
Cephalexin—Leukopenia—Dactinomycin—uterine cancer	0.000959	0.0028	CcSEcCtD
Cephalexin—Colitis—Epirubicin—uterine cancer	0.000955	0.00278	CcSEcCtD
Cephalexin—Blood urea increased—Epirubicin—uterine cancer	0.000939	0.00274	CcSEcCtD
Cephalexin—Vaginal infection—Epirubicin—uterine cancer	0.000939	0.00274	CcSEcCtD
Cephalexin—Hepatobiliary disease—Etoposide—uterine cancer	0.000939	0.00274	CcSEcCtD
Cephalexin—Aplastic anaemia—Epirubicin—uterine cancer	0.000934	0.00272	CcSEcCtD
Cephalexin—Agranulocytosis—Etoposide—uterine cancer	0.000926	0.0027	CcSEcCtD
Cephalexin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000924	0.00269	CcSEcCtD
Cephalexin—Vaginal inflammation—Doxorubicin—uterine cancer	0.00092	0.00268	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.00092	0.00268	CcSEcCtD
Cephalexin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000917	0.00267	CcSEcCtD
Cephalexin—Hypersensitivity—Progesterone—uterine cancer	0.000912	0.00266	CcSEcCtD
Cephalexin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000891	0.0026	CcSEcCtD
Cephalexin—Asthenia—Progesterone—uterine cancer	0.000888	0.00259	CcSEcCtD
Cephalexin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000886	0.00258	CcSEcCtD
Cephalexin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000886	0.00258	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—uterine cancer	0.000884	0.00257	CcSEcCtD
Cephalexin—Urinary tract disorder—Etoposide—uterine cancer	0.00088	0.00256	CcSEcCtD
Cephalexin—Pruritus—Progesterone—uterine cancer	0.000875	0.00255	CcSEcCtD
Cephalexin—Urethral disorder—Etoposide—uterine cancer	0.000873	0.00255	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—uterine cancer	0.000869	0.00253	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—uterine cancer	0.000869	0.00253	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—uterine cancer	0.000864	0.00252	CcSEcCtD
Cephalexin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000856	0.0025	CcSEcCtD
Cephalexin—Diarrhoea—Progesterone—uterine cancer	0.000847	0.00247	CcSEcCtD
Cephalexin—SLC15A2—lymph node—uterine cancer	0.000845	0.0121	CbGeAlD
Cephalexin—Erythema multiforme—Etoposide—uterine cancer	0.000842	0.00246	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.00083	0.00242	CcSEcCtD
Cephalexin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000826	0.00241	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—uterine cancer	0.000826	0.00241	CcSEcCtD
Cephalexin—CYP3A4—female reproductive system—uterine cancer	0.000824	0.0118	CbGeAlD
Cephalexin—Dizziness—Progesterone—uterine cancer	0.000818	0.00238	CcSEcCtD
Cephalexin—CYP2D6—female reproductive system—uterine cancer	0.00081	0.0116	CbGeAlD
Cephalexin—Immune system disorder—Etoposide—uterine cancer	0.000805	0.00235	CcSEcCtD
Cephalexin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000805	0.00234	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000797	0.00232	CcSEcCtD
Cephalexin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000793	0.00231	CcSEcCtD
Cephalexin—Vomiting—Progesterone—uterine cancer	0.000787	0.00229	CcSEcCtD
Cephalexin—Rash—Progesterone—uterine cancer	0.00078	0.00227	CcSEcCtD
Cephalexin—Dermatitis—Progesterone—uterine cancer	0.00078	0.00227	CcSEcCtD
Cephalexin—Headache—Progesterone—uterine cancer	0.000775	0.00226	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000768	0.00224	CcSEcCtD
Cephalexin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000767	0.00224	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000764	0.00223	CcSEcCtD
Cephalexin—Fatigue—Dactinomycin—uterine cancer	0.000754	0.0022	CcSEcCtD
Cephalexin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000741	0.00216	CcSEcCtD
Cephalexin—CYP2D6—female gonad—uterine cancer	0.000737	0.0106	CbGeAlD
Cephalexin—Nausea—Progesterone—uterine cancer	0.000735	0.00214	CcSEcCtD
Cephalexin—SLC22A5—lymph node—uterine cancer	0.000735	0.0106	CbGeAlD
Cephalexin—Osteoarthritis—Epirubicin—uterine cancer	0.000722	0.0021	CcSEcCtD
Cephalexin—Feeling abnormal—Dactinomycin—uterine cancer	0.000721	0.0021	CcSEcCtD
Cephalexin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000715	0.00208	CcSEcCtD
Cephalexin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000713	0.00208	CcSEcCtD
Cephalexin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.00206	CcSEcCtD
Cephalexin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000706	0.00206	CcSEcCtD
Cephalexin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000702	0.00205	CcSEcCtD
Cephalexin—Leukopenia—Etoposide—uterine cancer	0.000694	0.00202	CcSEcCtD
Cephalexin—Abdominal pain—Dactinomycin—uterine cancer	0.000691	0.00201	CcSEcCtD
Cephalexin—Body temperature increased—Dactinomycin—uterine cancer	0.000691	0.00201	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—uterine cancer	0.000676	0.00197	CcSEcCtD
Cephalexin—Convulsion—Etoposide—uterine cancer	0.000672	0.00196	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—uterine cancer	0.000668	0.00195	CcSEcCtD
Cephalexin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000666	0.00194	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000656	0.00191	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—uterine cancer	0.000652	0.0019	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00065	0.00189	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00065	0.00189	CcSEcCtD
Cephalexin—Hypersensitivity—Dactinomycin—uterine cancer	0.000644	0.00188	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—uterine cancer	0.000639	0.00186	CcSEcCtD
Cephalexin—Confusional state—Etoposide—uterine cancer	0.000638	0.00186	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000637	0.00186	CcSEcCtD
Cephalexin—Anaphylactic shock—Etoposide—uterine cancer	0.000633	0.00184	CcSEcCtD
Cephalexin—Asthenia—Dactinomycin—uterine cancer	0.000628	0.00183	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—uterine cancer	0.000626	0.00182	CcSEcCtD
Cephalexin—Thrombocytopenia—Etoposide—uterine cancer	0.00062	0.00181	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—uterine cancer	0.000618	0.0018	CcSEcCtD
Cephalexin—Skin disorder—Etoposide—uterine cancer	0.000615	0.00179	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—uterine cancer	0.000604	0.00176	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000602	0.00175	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000602	0.00175	CcSEcCtD
Cephalexin—Diarrhoea—Dactinomycin—uterine cancer	0.000598	0.00174	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—uterine cancer	0.000593	0.00173	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—uterine cancer	0.000591	0.00172	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000589	0.00172	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—uterine cancer	0.000583	0.0017	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—uterine cancer	0.000572	0.00167	CcSEcCtD
Cephalexin—Infestation—Epirubicin—uterine cancer	0.000556	0.00162	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—uterine cancer	0.000556	0.00162	CcSEcCtD
Cephalexin—Vomiting—Dactinomycin—uterine cancer	0.000556	0.00162	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000552	0.00161	CcSEcCtD
Cephalexin—Rash—Dactinomycin—uterine cancer	0.000551	0.00161	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—uterine cancer	0.000548	0.0016	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Etoposide—uterine cancer	0.000547	0.00159	CcSEcCtD
Cephalexin—Fatigue—Etoposide—uterine cancer	0.000546	0.00159	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—uterine cancer	0.00054	0.00157	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000526	0.00153	CcSEcCtD
Cephalexin—Feeling abnormal—Etoposide—uterine cancer	0.000522	0.00152	CcSEcCtD
Cephalexin—Nausea—Dactinomycin—uterine cancer	0.00052	0.00151	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—uterine cancer	0.000519	0.00151	CcSEcCtD
Cephalexin—Gastrointestinal pain—Etoposide—uterine cancer	0.000518	0.00151	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—uterine cancer	0.000515	0.0015	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—uterine cancer	0.000515	0.0015	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00051	0.00149	CcSEcCtD
Cephalexin—Urticaria—Etoposide—uterine cancer	0.000503	0.00147	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—uterine cancer	0.000502	0.00146	CcSEcCtD
Cephalexin—Abdominal pain—Etoposide—uterine cancer	0.0005	0.00146	CcSEcCtD
Cephalexin—Body temperature increased—Etoposide—uterine cancer	0.0005	0.00146	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—uterine cancer	0.000499	0.00146	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—uterine cancer	0.000499	0.00146	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—uterine cancer	0.000493	0.00144	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—uterine cancer	0.000491	0.00143	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—uterine cancer	0.00049	0.00143	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000487	0.00142	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—uterine cancer	0.00048	0.0014	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—uterine cancer	0.000472	0.00138	CcSEcCtD
Cephalexin—Hypersensitivity—Etoposide—uterine cancer	0.000466	0.00136	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—uterine cancer	0.000464	0.00135	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—uterine cancer	0.000462	0.00135	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—uterine cancer	0.000462	0.00135	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000456	0.00133	CcSEcCtD
Cephalexin—Asthenia—Etoposide—uterine cancer	0.000454	0.00132	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000454	0.00132	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—uterine cancer	0.000453	0.00132	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—uterine cancer	0.000451	0.00131	CcSEcCtD
Cephalexin—Pruritus—Etoposide—uterine cancer	0.000448	0.00131	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—uterine cancer	0.000438	0.00128	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—uterine cancer	0.000437	0.00127	CcSEcCtD
Cephalexin—Diarrhoea—Etoposide—uterine cancer	0.000433	0.00126	CcSEcCtD
Cephalexin—Dizziness—Etoposide—uterine cancer	0.000419	0.00122	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—uterine cancer	0.000417	0.00122	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—uterine cancer	0.000405	0.00118	CcSEcCtD
Cephalexin—Vomiting—Etoposide—uterine cancer	0.000402	0.00117	CcSEcCtD
Cephalexin—Agitation—Epirubicin—uterine cancer	0.0004	0.00116	CcSEcCtD
Cephalexin—Rash—Etoposide—uterine cancer	0.000399	0.00116	CcSEcCtD
Cephalexin—Dermatitis—Etoposide—uterine cancer	0.000399	0.00116	CcSEcCtD
Cephalexin—Headache—Etoposide—uterine cancer	0.000397	0.00116	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—uterine cancer	0.000389	0.00113	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—uterine cancer	0.000377	0.0011	CcSEcCtD
Cephalexin—Nausea—Etoposide—uterine cancer	0.000376	0.0011	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—uterine cancer	0.00037	0.00108	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—uterine cancer	0.00037	0.00108	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000368	0.00107	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—uterine cancer	0.00036	0.00105	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—uterine cancer	0.000358	0.00104	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—uterine cancer	0.000355	0.00103	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—uterine cancer	0.000349	0.00102	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—uterine cancer	0.000348	0.00101	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—uterine cancer	0.000347	0.00101	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—uterine cancer	0.000345	0.001	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—uterine cancer	0.000342	0.000998	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.00034	0.000991	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—uterine cancer	0.000331	0.000965	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000328	0.000957	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000323	0.000942	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—uterine cancer	0.000322	0.000938	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000321	0.000937	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—uterine cancer	0.000319	0.000929	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—uterine cancer	0.000312	0.00091	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000306	0.000893	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—uterine cancer	0.000306	0.000892	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000299	0.000872	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—uterine cancer	0.000292	0.000852	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—uterine cancer	0.00029	0.000846	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—uterine cancer	0.000289	0.000842	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000283	0.000826	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—uterine cancer	0.000283	0.000825	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—uterine cancer	0.000282	0.000821	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—uterine cancer	0.000281	0.000817	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—uterine cancer	0.000281	0.000817	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—uterine cancer	0.000271	0.000788	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000268	0.000782	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—uterine cancer	0.000261	0.000762	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—uterine cancer	0.000261	0.00076	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—uterine cancer	0.00026	0.000756	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—uterine cancer	0.00026	0.000756	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—uterine cancer	0.000255	0.000742	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—uterine cancer	0.000251	0.000732	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—uterine cancer	0.000243	0.000708	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—uterine cancer	0.000242	0.000705	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—uterine cancer	0.000236	0.000686	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—uterine cancer	0.000235	0.000684	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—uterine cancer	0.000232	0.000677	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—uterine cancer	0.000226	0.000657	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—uterine cancer	0.000225	0.000655	CcSEcCtD
Cephalexin—Rash—Epirubicin—uterine cancer	0.000224	0.000652	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—uterine cancer	0.000224	0.000651	CcSEcCtD
Cephalexin—Headache—Epirubicin—uterine cancer	0.000222	0.000648	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—uterine cancer	0.000217	0.000633	CcSEcCtD
Cephalexin—Nausea—Epirubicin—uterine cancer	0.000211	0.000614	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—uterine cancer	0.000209	0.000608	CcSEcCtD
Cephalexin—Rash—Doxorubicin—uterine cancer	0.000207	0.000603	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—uterine cancer	0.000207	0.000603	CcSEcCtD
Cephalexin—Headache—Doxorubicin—uterine cancer	0.000206	0.000599	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—uterine cancer	0.000195	0.000568	CcSEcCtD
